Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: Dosimetry calculations incorporating cross-organ beta doses
- 1 January 1996
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 23 (1) , 1-8
- https://doi.org/10.1016/0969-8051(95)02001-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Current status of radioimmunotherapyNuclear Medicine and Biology, 1994
- Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenograftsInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody.Journal of Clinical Oncology, 1991
- Radioimmunology. Imaging and therapyCancer, 1991
- Radiolabeled Monoclonal Antibody 15 and Its Fragments for Localization and Imaging of Xenografts of Human Lung CancerJNCI Journal of the National Cancer Institute, 1988
- A comparison of iodine and indium labelled anti CEA intact antibody, F(ab)2 and Fab fragments by imaging tumour xenograftsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1988
- Complete Tumor Ablation With Iodine 131-Radiolabeled Disialoganglioside GD2-Specific Monoclonal Antibody Against Human Neuroblastoma Xenografted in Nude Mice23JNCI Journal of the National Cancer Institute, 1986
- Comparative imaging and biodistribution studies with an anti-CEA monoclonal antibody and its F(ab)2 and Fab fragments in mice with colon carcinoma xenograftsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1986
- Selective tumor localization of radiolabeled anti-human melanoma monoclonal antibody fragment demonstrated in the nude mouse modelCancer, 1986
- Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.The Journal of Experimental Medicine, 1983